Total Payments
$11,451
2024 Payments
$19.40
Companies
23
Transactions
51
Medicare Patients
89
Medicare Billing
$10,349
Payment Breakdown by Category
Research$10,706 (93.5%)
Food & Beverage$745.13 (6.5%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Unspecified | $10,706 | 11 | 93.5% |
| Food and Beverage | $745.13 | 40 | 6.5% |
Payments by Type
Research
$10,706
11 transactions
General
$745.13
40 transactions
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Takeda Pharmaceuticals U.S.A., Inc. | $8,868 | 4 | $0 (2018) |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | $1,838 | 7 | $0 (2017) |
| Otsuka America Pharmaceutical, Inc. | $85.24 | 1 | $0 (2017) |
| Supernus Pharmaceuticals, Inc. | $83.57 | 5 | $0 (2022) |
| Merck Sharp & Dohme LLC | $71.33 | 4 | $0 (2023) |
| Ironshore Pharmaceuticals Inc. | $70.75 | 4 | $0 (2022) |
| Adlon Therapeutics L.P. | $67.80 | 4 | $0 (2021) |
| SANOFI PASTEUR INC. | $52.86 | 3 | $0 (2021) |
| Neurocrine Biosciences, Inc. | $42.97 | 2 | $0 (2023) |
| Sunovion Pharmaceuticals Inc. | $40.26 | 4 | $0 (2020) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $19.40 | 1 | Tris Pharma Inc ($19.40) |
| 2023 | $42.34 | 2 | Neurocrine Biosciences, Inc. ($26.75) |
| 2022 | $180.74 | 10 | Supernus Pharmaceuticals, Inc. ($48.61) |
| 2021 | $148.42 | 8 | Supernus Pharmaceuticals, Inc. ($34.96) |
| 2020 | $147.18 | 9 | Adlon Therapeutics L.P. ($52.31) |
| 2019 | $40.52 | 3 | SANOFI PASTEUR INC. ($26.79) |
| 2018 | $8,897 | 7 | Takeda Pharmaceuticals U.S.A., Inc. ($8,868) |
| 2017 | $1,976 | 11 | Otsuka Pharmaceutical Development & Commercialization, Inc. ($1,838) |
All Payment Transactions
51 individual payment records from CMS Open Payments — Page 1 of 3
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 09/12/2024 | Tris Pharma Inc | Dyanavel XR (Drug) | Food and Beverage | In-kind items and services | $19.40 | General |
| Category: ADHD | ||||||
| 02/28/2023 | Merck Sharp & Dohme LLC | ROTATEQ (Biological), VAXNEUVANCE, GARDASIL 9 | Food and Beverage | In-kind items and services | $15.59 | General |
| Category: VACCINE | ||||||
| 01/12/2023 | Neurocrine Biosciences, Inc. | — | Food and Beverage | In-kind items and services | $26.75 | General |
| 12/19/2022 | Supernus Pharmaceuticals, Inc. | QELBREE (Drug) | Food and Beverage | Cash or cash equivalent | $12.24 | General |
| Category: PSYCHOLOGY | ||||||
| 10/24/2022 | Cranial Technologies, Inc | Doc Band (Device) | Food and Beverage | Cash or cash equivalent | $17.27 | General |
| Category: Cranial Orthotic | ||||||
| 09/26/2022 | Ironshore Pharmaceuticals Inc. | JORNAY PM (Drug) | Food and Beverage | In-kind items and services | $14.51 | General |
| Category: Central Nervous Stimulant ADHD | ||||||
| 09/12/2022 | Corium, LLC | AZSTARYS (Drug) | Food and Beverage | In-kind items and services | $24.46 | General |
| Category: CNS Stimulant for ADHD | ||||||
| 08/23/2022 | Ironshore Pharmaceuticals Inc. | JORNAY PM (Drug) | Food and Beverage | In-kind items and services | $20.37 | General |
| Category: Central Nervous Stimulant ADHD | ||||||
| 07/13/2022 | Merck Sharp & Dohme LLC | GARDASIL 9 (Biological), ROTATEQ, PNEUMOVAX 23 | Food and Beverage | In-kind items and services | $16.22 | General |
| Category: VACCINE | ||||||
| 05/18/2022 | Hologic, LLC | THIRD WAVE (Device), THINPREP 2000 PROCESSOR, APTIMA | Food and Beverage | In-kind items and services | $19.81 | General |
| Category: Diagnostics | ||||||
| 04/13/2022 | Merck Sharp & Dohme LLC | GARDASIL 9 (Biological), ROTATEQ, PROQUAD | Food and Beverage | In-kind items and services | $19.49 | General |
| Category: VACCINE | ||||||
| 03/01/2022 | Supernus Pharmaceuticals, Inc. | QELBREE (Drug) | Food and Beverage | Cash or cash equivalent | $14.86 | General |
| Category: PSYCHOLOGY | ||||||
| 01/18/2022 | Supernus Pharmaceuticals, Inc. | QELBREE (Drug) | Food and Beverage | Cash or cash equivalent | $21.51 | General |
| Category: PSYCHOLOGY | ||||||
| 12/14/2021 | Seqirus USA Inc | FLUCELVAX QUADRIVALENT (Biological) | Food and Beverage | In-kind items and services | $17.39 | General |
| Category: Vaccines | ||||||
| 12/07/2021 | Supernus Pharmaceuticals, Inc. | QELBREE (Drug) | Food and Beverage | Cash or cash equivalent | $18.73 | General |
| Category: PSYCHOLOGY | ||||||
| 11/18/2021 | Ironshore Pharmaceuticals Inc. | JORNAY PM (Drug) | Food and Beverage | In-kind items and services | $18.26 | General |
| Category: Central Nervous Stimulant ADHD | ||||||
| 10/13/2021 | Merck Sharp & Dohme Corporation | GARDASIL 9 (Biological), VAXELIS | Food and Beverage | In-kind items and services | $20.03 | General |
| Category: VACCINE | ||||||
| 10/01/2021 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $16.22 | General |
| Category: NEUROLOGY | ||||||
| 09/22/2021 | Supernus Pharmaceuticals, Inc. | QELBREE (Drug) | Food and Beverage | Cash or cash equivalent | $16.23 | General |
| Category: PSYCHOLOGY | ||||||
| 07/07/2021 | Adlon Therapeutics L.P. | ADHANSIA XR (Drug) | Food and Beverage | Cash or cash equivalent | $15.49 | General |
| Category: PRESCRIPTION STIMULANT | ||||||
| 06/01/2021 | SANOFI PASTEUR INC. | VAXELIS (Biological) | Food and Beverage | In-kind items and services | $26.07 | General |
| Category: Vaccines | ||||||
| 12/17/2020 | Adlon Therapeutics L.P. | ADHANSIA XR (Drug) | Food and Beverage | Cash or cash equivalent | $14.19 | General |
| Category: PRESCRIPTION STIMULANT | ||||||
| 09/16/2020 | SOBI, INC | SYNAGIS (Drug) | Food and Beverage | In-kind items and services | $17.56 | General |
| Category: IMMUNOLOGY | ||||||
| 08/12/2020 | GlaxoSmithKline, LLC. | BEXSERO (Biological) | Food and Beverage | In-kind items and services | $15.92 | General |
| Category: VACCINES | ||||||
| 08/05/2020 | Adlon Therapeutics L.P. | ADHANSIA XR (Drug) | Food and Beverage | Cash or cash equivalent | $20.74 | General |
| Category: PRESCRIPTION STIMULANT | ||||||
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| Open-Label, Single-Arm, Multicenter, Prospective, Phase 4, Interventional, Flexible Dose Study to Evaluate the Effectiveness of Vortioxetine on Goal Achievement After a Change in Antidepressant Medication for the Treatment of Subjects | Takeda Pharmaceuticals U.S.A., Inc. | $8,868 | 4 |
| A Phase 2, Multicenter, Randomized, Double-blind, Placebo- and Active-controlled Trial | Otsuka Pharmaceutical Development & Commercialization, Inc. | $1,838 | 7 |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2021 | 2 | 35 | 68 | $9,588 | $4,339 |
| 2020 | 2 | 54 | 95 | $13,559 | $6,010 |
Total Patients
89
Total Services
163
Medicare Billing
$10,349
Procedure Codes
4
All Medicare Procedures & Services
4 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 90832 | Psychotherapy, 30 minutes | Office | 2021 | 24 | 45 | $6,150 | $2,529 | 41.1% |
| 90834 | Psychotherapy, 45 minutes | Office | 2021 | 11 | 23 | $3,438 | $1,810 | 52.6% |
| 90832 | Psychotherapy, 30 minutes | Office | 2020 | 30 | 58 | $8,120 | $3,312 | 40.8% |
| 90834 | Psychotherapy, 45 minutes | Office | 2020 | 24 | 37 | $5,439 | $2,698 | 49.6% |
About Dr. Andrew Sedillo, MD
Dr. Andrew Sedillo, MD is a Psychiatry healthcare provider based in Aurora, Colorado. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/14/2006. The National Provider Identifier (NPI) number assigned to this provider is 1144263179.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Andrew Sedillo, MD has received a total of $11,451 in payments from pharmaceutical and medical device companies, with $19.40 received in 2024. These payments were reported across 51 transactions from 23 companies. The most common payment nature is "" ($10,706).
As a Medicare-enrolled provider, Sedillo has provided services to 89 Medicare beneficiaries, totaling 163 services with total Medicare billing of $10,349. Data is available for 2 years (2020–2021), covering 4 distinct procedure/service records.
Ad
Practice Information
- Specialty Psychiatry
- Other Specialties Psychiatry, Psychiatry
- Location Aurora, CO
- Active Since 06/14/2006
- Last Updated 04/10/2023
- Taxonomy Code 2084P0800X
- Entity Type Individual
- NPI Number 1144263179
Products in Payments
- Trintellix (Drug) $8,868
- BREXPIPRAZOLE (Drug) $1,838
- REXULTI (Drug) $85.24
- QELBREE (Drug) $83.57
- JORNAY PM (Drug) $70.75
- ADHANSIA XR (Drug) $67.80
- GARDASIL 9 (Biological) $55.74
- LATUDA (Drug) $40.26
- VAXELIS (Biological) $26.07
- AZSTARYS (Drug) $24.46
- INVEGA SUSTENNA (Drug) $21.40
- Aristada 441 mg (Drug) $20.72
- THIRD WAVE (Device) $19.81
- Dyanavel XR (Drug) $19.40
- DIVIGEL (Drug) $18.09
- SYNAGIS (Drug) $17.56
- FLUCELVAX QUADRIVALENT (Biological) $17.39
- Doc Band (Device) $17.27
- INGREZZA (Drug) $16.22
- BEXSERO (Biological) $15.92
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Psychiatry Doctors in Aurora
Cynthia Epperson, Md, MD
Psychiatry — Payments: $46,633
Psychiatry $46,633
Justin Ryder, M.d, M.D
Psychiatry — Payments: $35,424
Psychiatry $35,424
Dr. Eric French, D.o, D.O
Psychiatry — Payments: $10,033
Psychiatry $10,033
Rachel Davis, Md, MD
Psychiatry — Payments: $5,690
Psychiatry $5,690
Dr. Kishwar Ali, M.d, M.D
Psychiatry — Payments: $4,981
Psychiatry $4,981
Dr. Syed Amanullah, Md, MD
Psychiatry — Payments: $4,760
Psychiatry $4,760